Buserelin acetate

This classification denotes the acetate form of a gonadotropin-releasing hormone analog with the molecular formula C60H86N16O13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PXW8U3YXDV, chemically known as luteinizing hormone-releasing hormone (pig), 6-(o-(1,1-dimethylethyl)-d-serine)-9-(n-ethyl-l-prolinamide)-10-deglycinamide- but more generally known as buserelin, which bears US NIH Compound Identifier 42615. Buserelin most often comes in base and acetate forms. European Medicines Agency schedules Buserelin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05991MIG. The term BUSERELIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules buserelin in its Anatomical Therapeutic Chemical (ATC) Classification. BUSERELIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule buserelin acetate under HS 29371900 and SITC 54154. As of Q4 2014, BUSERELIN ACETATE remains US FDA's Preferred Term for this commodity. Buserelin acetate bears US NLM identifiers UMLS ID C0600174 and NCI Concept Code C84460. SMILES: CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC2CCC(CC2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3C[NH]C4C3CCCC4)NC(=O)[C@H](CC5CNC[NH]5)NC(=O)[C@@H]6CCC(=O)N6.CC(=O)O.